Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CHA Cord Blood Bank, widely known by its brand name i-CORD, is a premier cord blood storage and research institution based in South Korea and operated by CHA Biotech. As a core component of the global CHA Health Systems network, it provides both private and public cord blood banking services, specializing in the long-term cryopreservation of hematopoietic and mesenchymal stem cells. The bank is deeply integrated with CHA Medical Center's clinical infrastructure, facilitating advanced research into regenerative medicine and cell-based therapies. Its stored units support treatments for various hematological malignancies and are central to ongoing clinical trials for neurological conditions such as cerebral palsy and autism. i-CORD is recognized for its high standards in cell processing and its contribution to the development of next-generation stem cell products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CHA Medical Center Cord Blood Bank.